Company Filing History:
Years Active: 2019
Title: Shimon Hassin: Innovator in Influenza Vaccine Development
Introduction
Shimon Hassin is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza. His innovative work has led to advancements in pharmaceutical compositions that aim to enhance the efficacy of immunization.
Latest Patents
Hassin holds a patent for "Compositions of multimeric-multiepitope influenza polypeptides and their production." This patent focuses on pharmaceutical suspensions of multimeric-multiepitope influenza polypeptides, detailing processes for their production and their use as immunizing subjects against influenza. In particular, the patent discloses stable aqueous microparticulate suspensions of a multimeric multiepitope polypeptide, which represents a significant advancement in vaccine technology.
Career Highlights
Shimon Hassin is associated with Biondvax Pharmaceuticals Ltd., a company dedicated to developing innovative solutions for influenza prevention. His work at Biondvax has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of vaccine research and development.
Collaborations
Hassin has collaborated with notable colleagues such as Ram Uritski and Barry Cohen. These partnerships have fostered a collaborative environment that enhances the research and development process within the company.
Conclusion
Shimon Hassin's contributions to the field of influenza vaccine development through his innovative patent and work at Biondvax Pharmaceuticals Ltd. highlight his importance as an inventor in the pharmaceutical industry. His efforts continue to pave the way for advancements in immunization strategies against influenza.